Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Latika Puri

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Cochrane Database of Systematic Reviews|September 19, 2019
Splenectomy for people with thalassaemia major or intermediaAkshay Sharma, Manu Easow Mathew, Latika Puri
The Cochrane Database of Systematic Reviews|April 21, 2021
Hematopoietic stem cell transplantation for people with β-thalassaemiaAkshay Sharma, Vanitha A Jagannath, Latika Puri
Pediatric Blood & Cancer|February 11, 2022
Prevalence of neuropathic pain in adolescents with sickle cell disease: A single-center experienceMelissa Cregan, Latika Puri, Guolian Kang, et al.
Current Opinion in Supportive and Palliative Care|June 4, 2019
Ketamine and lidocaine infusions decrease opioid consumption during vaso-occlusive crisis in adolescents with sickle cell diseaseLatika Puri, Kyle J Morgan, Doralina L Anghelescu
Paediatric Drugs|August 31, 2017
State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell DiseaseLatika Puri, Kerri A Nottage, Jane S Hankins, et al.
Ejhaem|December 5, 2022
COVID-19 infection and pain in adolescents with sickle cell disease: A case seriesHeidi M Heyman, Nicole M Alberts, Matthew Rees, et al.
Ejhaem|July 18, 2022
Gabapentin for acute pain in sickle cell disease: A randomized double-blinded placebo-controlled phase II clinical trialLatika Puri, Kerri Nottage, Jane S Hankins, et al.
Oncogene|February 27, 2024
AF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesisBabak Oskouian, Joanna Y Lee, Shahab Asgharzadeh, et al.
Investigational New Drugs|April 30, 2019
Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathwayPiming Zhao, Ana E Aguilar, Joanna Y Lee, et al.
Investigational New Drugs|January 17, 2018
Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathwayPiming Zhao, Ana E Aguilar, Joanna Y Lee, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Cochrane Database of Systematic Reviews|September 19, 2019
Splenectomy for people with thalassaemia major or intermediaAkshay Sharma, Manu Easow Mathew, Latika Puri
The Cochrane Database of Systematic Reviews|April 21, 2021
Hematopoietic stem cell transplantation for people with β-thalassaemiaAkshay Sharma, Vanitha A Jagannath, Latika Puri
Pediatric Blood & Cancer|February 11, 2022
Prevalence of neuropathic pain in adolescents with sickle cell disease: A single-center experienceMelissa Cregan, Latika Puri, Guolian Kang, et al.
Current Opinion in Supportive and Palliative Care|June 4, 2019
Ketamine and lidocaine infusions decrease opioid consumption during vaso-occlusive crisis in adolescents with sickle cell diseaseLatika Puri, Kyle J Morgan, Doralina L Anghelescu
Paediatric Drugs|August 31, 2017
State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell DiseaseLatika Puri, Kerri A Nottage, Jane S Hankins, et al.
Ejhaem|December 5, 2022
COVID-19 infection and pain in adolescents with sickle cell disease: A case seriesHeidi M Heyman, Nicole M Alberts, Matthew Rees, et al.
Ejhaem|July 18, 2022
Gabapentin for acute pain in sickle cell disease: A randomized double-blinded placebo-controlled phase II clinical trialLatika Puri, Kerri Nottage, Jane S Hankins, et al.
Oncogene|February 27, 2024
AF1q is a universal marker of neuroblastoma that sustains N-Myc expression and drives tumorigenesisBabak Oskouian, Joanna Y Lee, Shahab Asgharzadeh, et al.
Investigational New Drugs|April 30, 2019
Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathwayPiming Zhao, Ana E Aguilar, Joanna Y Lee, et al.
Investigational New Drugs|January 17, 2018
Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathwayPiming Zhao, Ana E Aguilar, Joanna Y Lee, et al.
Pageof 2